English | Español

Stanford University School Of Medicine
+ Community
Mia Sims | Jul 17, 2017

Study indicates ibuprofen a risk for marathon runners
+ Technology/Innovation
Amanda Rupp | Jun 29, 2016

Atrial flutter patients receive updated performance, quality measures

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes